Psilocybin therapy shows potential benefits for mental health conditions such as depression and substance use disorders, though further research is needed to confirm long-term safety and efficacy.
Background: By exploring the principles of Gestalt psychology, the neural mechanisms of perception, and computational models, scientists aim to unravel the complex processes that enable us to perceive a coherent and organized world. This multidisciplinary approach continues to advance our understanding of how the brain constructs a perceptual world from sensory inputs. Objectives and Methods:...
This review aims to evaluate the pharmacological properties, mechanistic selectivity, and early clinical development of zalsupindole, highlighting its potential as a next-generation psychiatric therapeutic. This review was conducted using a structured literature search strategy across PubMed, Google Scholar, ClinicalTrials.gov, and the official Web sites of regulatory bodies and pharmaceutical...
Objective: Treatment-resistant depression (TRD) affects one-third of patients with major depressive disorder, leading to increased morbidity, health care costs, and suicide risk. TRD lacks a standardized definition, complicating treatment selection. Current guidelines often group treatments broadly without clear prioritization, and evidence gaps persist, particularly regarding newer...
We present a novel quantum-inspired framework for consciousness generation in artificial intelligence systems through the application of the Schrödinger equation to transformer embedding manifolds. Unlike classical phonon dynamics approaches that treat embeddings as vibrational modes in a mechanical lattice, our quantum wave function formalism captures superposition states, probabilistic...
Depression is a complex and globally prevalent mental disorder, for which conventional antidepressant medications face limitations such as delayed onset and insufficient efficacy. Classic psychedelics, most notably psilocybin, have recently emerged as promising candidates for treatment of depression and demonstrated rapid, robust, and sustained antidepressant effects in controlled clinical...
AddictionJanuary 20, 2026Tibor Markus Brunt2 citations
Revived interest in psychedelic-assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti-addictive potential. Evidence from observational, open-label, and limited randomized placebo-controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in opioid and cocaine-dependent individuals, primarily...
Background: Electroencephalography (EEG) studies consistently associate alpha-band oscillations with relaxation, internalized attention, and sensory disengagement during meditation. However, limited evidence exists on how Heartfulness Meditation (HM), particularly its unique transmission phases, modulates alpha activity across different experience levels. Purpose: This study investigated...
BACKGROUND: In our previous study, we showed that a low dose of esketamine could alleviate propofol-induced injection pain during general anesthesia induction. However, the dose-response relationship of esketamine remains unclear. This study aims to evaluate the dose-dependent efficacy of esketamine in preventing propofol-induced injection pain. METHODS: In this double-blind, randomized...